Search Results for "Insulin Infusion In Labor"
Original Source: Comparative Trial Between 3 Types of Insulin Infusion Protocols
Increasing evidence from observational studies in hospitalized patients with and without diabetes indicates that hyperglycemia is a predictor of poor outcome. Over the short-term, hyperglycemia can adversely affects fluid balance (through glycosuria and dehydration), impairs immunologic response to infection, and promotes inflammation and endothelial dysfunction. Blood glucose control with intensive insulin therapy in patients with acute critical illness reduces the risk of m...
Matching Channels
Matching News
Insulin Pump After Failure of Multiple Daily Injections
Does continuous subcutaneous insulin infusion work better than insulin injections for uncontrolled Type 2 diabetes? Endocrine Practice
Tandem Diabetes Gets JDRF Support For Dual-Chamber Infusion Pump
The project targets two main shortcomings of current infusion pumps, Tandem executives say: patients have to constantly monitor their own blood sugar levels, and current infusion pumps do not typicall...
Japanese panel backs approval of insulin degludec
Novo Nordisk A/S (CSE:NVO; NYSE:NVO) said a Japanese drug advisory committee issued a positive recommendation on a marketing application for insulin Degludec to treat Type I and Type II diabetes. Novo...
StnDrd Infusion Inc.’s StnDrd Infusion Therapy System streamlines general-purpose infusion pumps by combining within one device the ability to effectively and safely infuse all three classifications...
Novo Nordisk insulin degludec passes first regulatory hurdle in Japan
Danish insulin giant Novo Nordisk (NOV: N) revealed on Friday that its ultra-long-acting insulin degludec has passed the review by Japan's Ministry of Health, Labor and Welfare (MHLW) advisory committ...
EMA releases updated guidelines for biosimilar insulin products
EMA's CHMP released draft guidelines that update 2006 guidelines on the non-clinical and clinical requirements for biosimilar insulin products. The updated guidelines state that clinical studies shoul...
FDA Ups Insulin Pump Recall to Class I
WASHINGTON (MedPage Today) -- The FDA has issued a class I recall for the Animas 2020 insulin infusion pump due to false alarms that may trigger, cease device function, and cause serious adverse event...
Novo Nordisk now ready to launch Tresiba in Japan, following pricing accord
Danish insulin giant Novo Nordisk (NOV: N) yesterday announced that it has received approval of the price of Tresiba (insulin degludec), the new once-daily basal insulin for the treatment of type 1 an...
Matching PubMed Articles
Global IRS-1 phosphorylation analysis in insulin resistance.
AIMS/HYPOTHESIS: IRS-1 serine phosphorylation is often elevated in insulin resistance models, but confirmation in vivo in humans is lacking. We therefore analysed IRS-1 phosphorylation in human muscle...
The use of U-500 insulin in the management of highly insulin resistant diabetic patients is growing. There are a number of reports that have noted the effects of U-500 insulin using multiple daily inj...
Chronic central leptin infusion differently modulates brain and liver insulin signaling.
Recent studies reported the impact of leptin on peripheral insulin sensitivity and glucose utilization. However, little is known concerning the effect of central leptin on hypothalamic and hepatic ins...
We infused the 48h intralipid plus heparin (IH) to normal rats to elevate plasma free fatty acids (FFAs). Co-infusion of taurine was designed for the purpose of studying the effects of taurine on insu...
Infusion of Mg in humans acutely reduces serum insulin levels: a pilot study.
Infusion of Mg for therapeutic purposes is still a matter for debate. Dosages vary considerably, yet subclinical effects on normal physiology are largely ignored. In human and animal models, interacti...
